The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $146.29

Today's change0.00 0.00%
Updated January 13 4:03 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $146.29

Today's change0.00 0.00%
Updated January 13 4:03 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc closed at (U.S.)$146.29.

Shares have lost 0.67% for the last five days, but have gained 9.36% over the last 52 weeks. This security has underperformed the S&P 500 by 11.61% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $146.29
  • High--
  • Low--
  • Bid / Ask(U.S.) $120.00 / (U.S.) $157.97
  • YTD % change+3.68%
  • Volume0
  • Average volume (10-day)1,844,208
  • Average volume (1-month)1,897,324
  • Average volume (3-month)1,908,938
  • 52-week range(U.S.) $119.75 to (U.S.) $160.68
  • Beta1.10
  • Trailing P/E29.20×
  • P/E 1 year forward17.73×
  • Forward PEG1.59×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.41%
  • Trailing EPS(U.S.) $5.01
Updated January 13 4:03 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Dec 31, 201512/31/2015
Revenue4,4914,5354,2954,653
Total other revenue--------
Total revenue4,4914,5354,2954,653
Gross profit2,0542,0791,9582,108
Total cost of revenue2,4372,4572,3372,544
Total operating expense3,9503,8983,7773,962
Selling / general / administrative1,2121,2191,1841,180
Research & development183182177180
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)117398058
Other operating expenses, total--------
Operating income541638518690
Interest income (expense), net non-operating-113-119-106-103
Gain (loss) on sale of assets--------
Other--------
Income before tax428521423583
Income after tax474517402606
Income tax, total-46421-24
Net income474517402603
Total adjustments to net income--------
Net income before extra. items474517402606
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items474517402606
Inc. avail. to common incl. extra. items474517402603
Diluted net income474517402603
Dilution adjustment--------
Diluted weighted average shares397397399403
Diluted EPS excluding extraordinary itemsvalue per share1.191.301.011.51
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.381.401.201.62